Kinza Muzaffar
Rheumatology · Shreveport, LANPI 1447601935
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,099 and has fallen 67.0% since, to $363 in 2025. That places this record below the midpoint for rheumatology clinicians in LA, where the typical reported total is $8,351.
Across 167 payments — averaging $20.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$814
- Johnson & Johnson$478
- Aurinia Pharma U.S., Inc.$260
- Boehringer Ingelheim$251
- GSK$234
- Genentech USA, Inc.$199
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,40999%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 41 | $814 |
| Johnson & Johnson(2 entities) | 25 | $478 |
| Aurinia Pharma U.S., Inc. | 15 | $260 |
| Boehringer Ingelheim | 9 | $251 |
| GSK | 15 | $234 |
| Genentech USA, Inc. | 11 | $199 |
| AbbVie | 6 | $169 |
| UCB, Inc. | 6 | $137 |
| Mallinckrodt Hospital Products Inc. | 2 | $136 |
| Novartis | 5 | $116 |
| Novo Nordisk | 5 | $108 |
| AstraZeneca | 6 | $98 |
| Kyowa Kirin, Inc. | 3 | $63 |
| Sobi, Inc | 2 | $56 |
| Pfizer | 3 | $56 |
| Lilly USA, LLC | 3 | $47 |
| Janssen Scientific Affairs, LLC | 1 | $36 |
| Bayer | 1 | $23 |
| Sanofi | 1 | $22 |
| Fresenius Kabi USA, LLC | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Octapharma USA, Inc. | 1 | $21 |
| Tonix Medicines, Inc. | 1 | $19 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Travere Therapeutics, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,429 in reported general payments places this provider in the 25th percentile of 88 rheumatology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready PenSecukinumab | 16 | $154,441 |
| Xeljanz XrTofacitinib Citrate | 16 | $107,401 |
| Humira PenAdalimumab | 11 | $73,105 |
| Teriparatide | 13 | $37,315 |
| Hydroxychloroquine Sulfate | 18 | $864 |
| MethotrexateMethotrexate Sodium | 34 | $616 |
| Methotrexate SodiumMethotrexate Sodium/Pf | 15 | $204 |
| Triamcinolone Acetonide | 12 | $140 |
| Prednisone | 23 | $131 |
| Alendronate Sodium | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Shreveport
- Aaron BroadwellShreveport$1.6M
- Frankie PedigoShreveport$98K
- Larry BroadwellShreveport$33K
- Mary WaltonShreveport$16K
- Mamatha KatikaneniShreveport$14K
- Robert GoodmanShreveport$14K
- Thomas PresslyShreveport$11K
- Sarwat UmerShreveport$8K
- Kyla LokitzShreveport$7K
- Samina HayatShreveport$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.